Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients

Joanna Wawryka; Ewa Barg

Pełna treść

2/2016 vol. 22

Artykuł przeglądowy

Wpływ ekspresji genu SIRT1 na rozwój i terapię zespołu metabolicznego u pacjentów onkologicznych

Joanna Wawryka

,

Ewa Barg

Pediatr Endocrinol Diabetes Metab 2016;22,2:60-65

Data publikacji online: 2017/03/20

Plik artykułu

a_36592.pdf

AMA

Wawryka J, Barg E. Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(2).

APA

Wawryka, J., & Barg, E. (2016). Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism, 22(2).

Chicago

Wawryka, Joanna, and Ewa Barg. 2016. "Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients". Pediatric Endocrinology Diabetes and Metabolism 22 (2).

Harvard

Wawryka, J., and Barg, E. (2016). Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism, 22(2).

MLA

Wawryka, Joanna et al. "Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients." Pediatric Endocrinology Diabetes and Metabolism, vol. 22, no. 2, 2016.

Vancouver

Wawryka J, Barg E. Impact of SIRT1 gene expression on the development and treatment of the metabolic syndrome in oncological patients. Pediatric Endocrinology Diabetes and Metabolism. 2016;22(2).

ZGŁASZANIE PRAC

Udostępnij

Zintergrowane z

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications